Results from human serum samples determined using the five-antigen multiplex assay. Results from human serum samples determined using the five-antigen.

Slides:

Advertisements

Similar presentations

RHEUMATOLOGY TESTING Maureen Sestito, D.O. PCOM Internal Medicine Residency.

Advertisements

Figure 3 Antibodies to MOG using different secondary antibodies: Anti-human IgG (H + L), IgG1, or IgM(A) Comparison of binding to full-length myelin oligodendrocyte.

Centers for Disease Control/Food and Drug Administration algorithm for second-generation HIV tests (20). †, an immunofluorescence assay (IFA) for HIV-1.

FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.

Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Figure 1 8-Iso-PGF2α levels in CSF of patients with MS and controlsCSF 8-iso-prostaglandin F2α (8-iso-PGF2α) levels were estimated using an ELISA. (A)

Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.

Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.

CCL19 levels are elevated in Lyme disease cases with PTLDS

Assessment of CD40L expression and function for diagnosis of X-linked hyper-IgM syndrome (XL-HIGM). Assessment of CD40L expression and function for diagnosis.

Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.

(Upper) Levels of antibodies (ELISA OD values) reactive with each of 16 recombinant proteins of S. zooepidemicus strain NC78 in 1:200 dilutions of convalescent-phase.

Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.

Western blot results for serum samples obtained from experimentally vaccinated dogs prior to and at various times (weeks) following initial vaccination.

Structure of a typical back-propagated multilayered perceptron used in this study. Structure of a typical back-propagated multilayered perceptron used.

(Left) Selected IgM immunoblot reactivities.

Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.

The severity of fatigue over 8 years of disease in early rheumatoid arthritis patients. The severity of fatigue over 8 years of disease in early rheumatoid.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Fig. 1 Anti-LtxA antibody concentrations in various patient groups.

Dynamic ranges of anti-PnPS IgG Reference standard serum 007sp for each of 13 serotypes. Dynamic ranges of anti-PnPS IgG Reference standard serum 007sp.

Figure 2. Detection of KIR4.1 autoantibodies using LIPS

Figure Avidity of IgG specific for influenza A and B following flu vaccinationAvidity of immunoglobulin (Ig) G specific for influenza A and B before and.

Contribution of individual serovars within serogroups isolated in the United States in Contribution of individual serovars within serogroups isolated.

Pulmonary vaccination induces a long-term immune memory response to antigen challenge. Pulmonary vaccination induces a long-term immune memory response.

Anti-inflammatory cytokine production is increased in trained monocytes. Anti-inflammatory cytokine production is increased in trained monocytes. (A) IL-10.

Reproducibility of LPA results for cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of LPA results for cryopreserved.

Viability and viable cell recovery of cryopreserved PBMC after variable periods of storage in liquid nitrogen. Viability and viable cell recovery of cryopreserved.

Figure 2 Detection of slanDCs in CSF of patients with MS(A, B) Immunocytochemical stainings were performed to determine the presence of 6-sulfo LacNAc+

Serum sRANKL and OPG levels in healthy donors and patients with RA at baseline and after MTX and low-dose prednisolone treatment. Serum sRANKL and OPG.

T. gondii-specific IgG antibodies in 32 pregnant women treated with spiramycin from the time of diagnosis until delivery and in 16 nonpregnant patients.

Antibody titers against surface antigens of B

FeLV p27 antigenemia ELISA data.

RTA pepscan analysis of sera from RiVax- and RVEc-immunized mice.

Predictive value of the FGFR3 mutation assay increases with multiple consecutive FGFR3-positive urine samples. Predictive value of the FGFR3 mutation assay.

Scattergrams showing IgG- and IgA-specific OD490 values measured with the Campylobacter-specific P18/P39 ELISA in sera from healthy controls and from GBS.

RTA-specific serum IgG antibody titers and TNA in mice immunized with RiVax or RVEc. RTA-specific serum IgG titers after the second (A) or third (B) immunizations.

NK activity in healthy donors (n=51) and patients with FRH upon recurrence (n=28) and remission (n=23). NK activity in healthy donors (n=51) and patients.

Dilution of anti-C6 monoclonal antibody shows the broader linear range of the Multiplex assay in comparison to standard ELISA. Shown is the dilution of.

Reproducibility of CD4+ and CD8+ T-cell enumeration with cryopreserved PBMC after variable periods of storage in liquid nitrogen. Reproducibility of CD4+

Reproducibility of the enumeration of the percentages of CD4+ CD45RA+ CD95−, CD4+ CD38+, and CD8+ CD38+ in cryopreserved PBMC after variable periods of.

Antibody titers against surface antigens of M

Relation between the total white blood count and the absolute lymphocyte count prior to the first vaccination and the response to vaccination. Relation.

Identification of the recombinant structural proteins expressed in recombinant baculovirus-infected Sf9 cells by immunofluorescence assay with rabbit anti-FMDV.

IgM-specific immunoblot analysis of different HCMV recombinant antigens with a selected serum sample from an HCMV-seronegative patient with acute EBV-induced.

DTH responses to multiple components of the ID93 fusion protein.

Unsupervised principal-component analysis (PCA) of 129 seroreactive antigens for adults and children from different geographical locations. Unsupervised.

Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),

TNA associated with FD3-specific Abs.

Group-averaged IL-10 levels (in pg/ml) from the Luminex assay for control, CFS with FM, and CFS without FM groups. Group-averaged IL-10 levels (in pg/ml)

Diethylamine-based measles avidity assay.

Long-lived antibody-secreting cells in the bone marrow, induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5%

Typical pattern of the degranulation of NK cells from a healthy donor (upper row) and a patient with FRH in recurrence (middle row) and in remission (lower.

Time to culling for mastitis among J5 vaccinates and controls

Distributions of levels of antibodies to periodontal pathogens and plasma vitamin C concentrations. Distributions of levels of antibodies to periodontal.

Antigen-specific cytokine production detected by multiplex bead assay (Luminex) 3 weeks after the 3rd immunization. Antigen-specific cytokine production.

Antigen-specific cytokine-producing cells (IFN-γ and IL-5) detected by ELISPOT assay 3 weeks after the 3rd immunization. Antigen-specific cytokine-producing.

Anti-PT IgG results from 227 patients with coughs of unknown etiology who reported the severity of cough on a scale from 0 to 10. Anti-PT IgG results from.

Optimization of incubation time for visibly stained spot formation in Vero-E6 infected by four serotype DENVs and the efficiency of DENV-4 plaque formation.

Lkt antibody titers of vaccinated and control groups of BHS

Schematic presentation of the major domains of Alps, the signal peptide (S), the N-terminal region (N), the repeat region (R), and the C-terminal region.

Time to culling for all reasons among J5 vaccinates and controls

Comparison of PD-L1 mAbs in IHC across multiple tumor types.

IgA and IgG antibodies reactive to TT, alpha-toxin, and BSA in two groups of chickens 2 weeks after oral gavage with probiotics or with PBS. The two groups.

Distribution of responses to vaccine antigens in the culture-positive individual group and the control group. Distribution of responses to vaccine antigens.

Fig. 1 Anti-LtxA antibody concentrations in various patient groups.

Variability between laboratories in titer estimations (expressed as GCV on the y axis) tends to be higher for samples in low measurement ranges and to.

Presentation transcript:

Results from human serum samples determined using the five-antigen multiplex assay. Results from human serum samples determined using the five-antigen multiplex assay. The MFI values (y axis) of antibodies to each particular antigen are indicated by colored bars. The patient categories are indicated below the x axis, according to the following key: healthy, from an area of endemicity (HE); healthy, from an area of nonendemicity (HNE); fibromyalgia (FB); infectious mononucleosis (MN); multiple sclerosis (MS); rheumatoid arthritis (RA); severe periodontitis (PD); syphilis (SY); early Lyme/acute phase (EL/A); early Lyme convalescent phase (EL/C); Lyme arthritis (LA); and neuroborreliosis (NL). Each sample indicated on the x axis represents an individual patient. Monica E. Embers et al. Clin. Vaccine Immunol. 2016; doi:10.1128/CVI.00685-15